Nanobiotix SA
PAR:NANO

Watchlist Manager
Nanobiotix SA Logo
Nanobiotix SA
PAR:NANO
Watchlist
Price: 3.74 EUR -1.32% Market Closed
Market Cap: 176.2m EUR
Have any thoughts about
Nanobiotix SA?
Write Note

EV/OCF
Enterprise Value to OCF

-139.6
Current
-6.8
Median
6
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-139.6
=
Enterprise Value
144.6m EUR
/
Operating Cash Flow
-1m EUR
All Countries
Close
Market Cap EV/OCF
FR
Nanobiotix SA
PAR:NANO
176.2m EUR -139.6
FR
Pharnext SCA
OTC:PNEXF
6T USD -236 051.4
US
Abbvie Inc
NYSE:ABBV
301B USD 21.3
US
Amgen Inc
NASDAQ:AMGN
162B USD 28.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.5B USD -128.2
US
Gilead Sciences Inc
NASDAQ:GILD
115.4B USD 11
US
Epizyme Inc
F:EPE
94.1B EUR -477
AU
CSL Ltd
ASX:CSL
138B AUD 35.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.6B USD 19.2
US
Seagen Inc
F:SGT
39.3B EUR -74.6
NL
argenx SE
XBRU:ARGX
34.1B EUR -126.8
 
FR
Nanobiotix SA
PAR:NANO
Average EV/OCF: 23.3
Negative Multiple: -139.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -236 051.4
US
Abbvie Inc
NYSE:ABBV
21.3
US
Amgen Inc
NASDAQ:AMGN
28.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -128.2
US
Gilead Sciences Inc
NASDAQ:GILD
11
US
E
Epizyme Inc
F:EPE
Negative Multiple: -477
AU
CSL Ltd
ASX:CSL
35.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -74.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -126.8

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More